source
- Amgen Announces Retirement of Chief Technology Officer David ReeseAmgen announced that longtime leader David Reese will retire at the end of June. Reese, 63, currently serves as the company's chief technology officer, a position he created in 2023 after many yea…
- Revolution Medicines' early-stage pancreatic cancer drug shows tumor control in half of patientsRevolution Medicines reported that its experimental therapy daraxonrasib helped control tumors in at least half of patients with early-stage pancreatic cancer, whether given alone or with chemother…